Role of the enteric nervous system in the fluid and electrolyte secretion of rotavirus diarrhea

Science

Volumn 287, Issue 5452, 2000, Pages 491-495

  Lundgren, Ove ^a   Peregrin, Attila Timar ^a   Persson, Kjell ^a   Kordasti, Shirin ^a   Uhnoo, Ingrid ^b   Svensson, Lennart ^c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTROLYTE; HEXAMETHONIUM; LIDOCAINE; MECAMYLAMINE; TETRODOTOXIN; THEOPHYLLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIARRHEA; ELECTROLYTE TRANSPORT; IN VITRO STUDY; IN VIVO STUDY; INTESTINE FLUID; INTESTINE INNERVATION; INTESTINE MUCOSA; INTESTINE SECRETION; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; ROTAVIRUS; SEROSA;

ANIMALS; ANIMALS, NEWBORN; BODY WATER; DIARRHEA; ELECTROLYTES; ENTERIC NERVOUS SYSTEM; HEXAMETHONIUM; INTESTINAL MUCOSA; INTESTINE, SMALL; LIDOCAINE; MECAMYLAMINE; MICE; MICE, INBRED BALB C; NICOTINIC ANTAGONISTS; PATCH-CLAMP TECHNIQUES; ROTAVIRUS INFECTIONS; SYNAPTIC TRANSMISSION; TETRODOTOXIN; THEOPHYLLINE;

ANIMALIA; ROTAVIRUS;

EID: 0034695527     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.287.5452.491     Document Type: Article

References (37)

1. Anonymous, WHO Weekly Epidemiologcal Record 1999, pp. 33-40.
2. W. G. Starkey et al., J. Gen. Virol. 67, 2625 (1986); K. Coelho, A. Bryden, C. Hall, T. Flewett, Ultrastruct. Pathol. 2, S9 (1981); L. Little and S. Ja, Infect. Immun. 38, 755 (1982); P. A. Offit, H. F. Clark, M. J. Kornstein, S. A. Plotkin, J. Virol. 51, 233 (1984).
3. W. G. Starkey et al., J. Gen. Virol. 67, 2625 (1986); K. Coelho, A. Bryden, C. Hall, T. Flewett, Ultrastruct. Pathol. 2, S9 (1981); L. Little and S. Ja, Infect. Immun. 38, 755 (1982); P. A. Offit, H. F. Clark, M. J. Kornstein, S. A. Plotkin, J. Virol. 51, 233 (1984).
4. W. G. Starkey et al., J. Gen. Virol. 67, 2625 (1986); K. Coelho, A. Bryden, C. Hall, T. Flewett, Ultrastruct. Pathol. 2, S9 (1981); L. Little and S. Ja, Infect. Immun. 38, 755 (1982); P. A. Offit, H. F. Clark, M. J. Kornstein, S. A. Plotkin, J. Virol. 51, 233 (1984).
5. W. G. Starkey et al., J. Gen. Virol. 67, 2625 (1986); K. Coelho, A. Bryden, C. Hall, T. Flewett, Ultrastruct. Pathol. 2, S9 (1981); L. Little and S. Ja, Infect. Immun. 38, 755 (1982); P. A. Offit, H. F. Clark, M. J. Kornstein, S. A. Plotkin, J. Virol. 51, 233 (1984).
6. G. P. Davidson et al., J. Clin. Pathol. 28, 263 (1975); G. P. Davidson and G. L. Barnes, Acta Paediatr. Scand. 68, 181 (1979); T. Köhler, U. Erben, H. Wiedersberg, N. Bannert, Kinderaerztl. Prax. 58, 323 (1990).
7. G. P. Davidson et al., J. Clin. Pathol. 28, 263 (1975); G. P. Davidson and G. L. Barnes, Acta Paediatr. Scand. 68, 181 (1979); T. Köhler, U. Erben, H. Wiedersberg, N. Bannert, Kinderaerztl. Prax. 58, 323 (1990).
8. G. P. Davidson et al., J. Clin. Pathol. 28, 263 (1975); G. P. Davidson and G. L. Barnes, Acta Paediatr. Scand. 68, 181 (1979); T. Köhler, U. Erben, H. Wiedersberg, N. Bannert, Kinderaerztl. Prax. 58, 323 (1990).
9. J. Stephen, in Proceedings of the Ninth BSG/SK&f International Workshop, British Society of Gastroenterology, Windsor, Berkshire, UK, 2 to 4 October 1988 (Smith, Kline and French Laboratories, Welwyn Garden City, Hertsfordshire, UK, 1989). A. J. Spencer et al., J. Pediatr. Gastroenterol. Nutr. 10, 516 (1990).
10. J. Stephen, in Proceedings of the Ninth BSG/SK&f International Workshop, British Society of Gastroenterology, Windsor, Berkshire, UK, 2 to 4 October 1988 (Smith, Kline and French Laboratories, Welwyn Garden City, Hertsfordshire, UK, 1989). A. J. Spencer et al., J. Pediatr. Gastroenterol. Nutr. 10, 516 (1990).
11. M. P. Osborne et al., J. Pediatr. Gastroenterol. Nutr. 7, 236 (1988); M. P. Osborne et al., J. Pediatr. Gastroenterot. Nutr. 12, 111 (1991).
12. M. P. Osborne et al., J. Pediatr. Gastroenterol. Nutr. 7, 236 (1988); M. P. Osborne et al., J. Pediatr. Gastroenterot. Nutr. 12, 111 (1991).
13. J. M. Ball, P. Tian, C. Q.-Y. Zeng, A. P. Morris, M. K. Estes, Science 272, 101 (1996).
14. J. Cassuto, M. Jodat, R. Tuttle, O. Lundgren, Scand. J. Gastroenterol. 16, 377 (1981).
15. M. Jodal and O. Lundgren, in Regulatory Mechanisms in Gastrointestinal Function, T. S. Gaginella, Ed. (CRC Press, Boca Raton, FL, 1995), pp. 99-144.
16. I. Brunsson, Acta Physiol. Scand. 131, 609 (1987); M. Jodal, U. Wingren, M. Jansson, M. Heidemann, O. Lundgren. Gut 34, 1526 (1993); I. Castagliuolo et. al., Gastroenterotogy 107, 657 (1994).
17. I. Brunsson, Acta Physiol. Scand. 131, 609 (1987); M. Jodal, U. Wingren, M. Jansson, M. Heidemann, O. Lundgren. Gut 34, 1526 (1993); I. Castagliuolo et. al., Gastroenterotogy 107, 657 (1994).
18. I. Brunsson, Acta Physiol. Scand. 131, 609 (1987); M. Jodal, U. Wingren, M. Jansson, M. Heidemann, O. Lundgren. Gut 34, 1526 (1993); I. Castagliuolo et. al., Gastroenterotogy 107, 657 (1994).
19. 2 (5%) in oxygen at 37°C. The transmural PD was monitored with a pair of calomel electrodes. Two types of Ussing chambers were used. In one type, the electrical field of the voltage clamp was perpendicular to the intestinal segment, which made it possible to estimate tissue resistance in absolute terms by using an automatic voltage damp device to measure SCC. PD and SCC were recorded on a polygraph. Values of PD and SCC reported in the text, tables, and figures are given as the mean ± SEM. After mounting the tissue, the PD was allowed to stabilize for about 30 min. In control experiments, PD and SCC remained constant in infected and noninfected animals after this stabilizing period (24). For testing of drugs, each tissue was exposed to one drug in increasing concentrations with a 10-min interval between administrations. The drugs used were administered in volumes of 20 μl. At the end of the experiments, 200 μl of theophylline solution was added to the mucosal and serosal solutions to a final concentration of 1 mM to test tissue viability. If theophylline increased the PD by less than 40% of the control value, the experiment was discarded.
20. O. Lundgren et al., data not shown.
21. -1) for at least 24 hours before use. In control experiments this procedure prevented any adsorbance of the tracer to the plastic tubing. After placing the segment in the organ bath, the intestine was perfused for 20 min without sampling. Then 20-min samples were collected in tubes at the outflow end of the perfusion system. In one series of experiments (Fig. 2), in which the viability of the intestinal preparation was tested, the perfusion fluid was sampled during three consecutive 20-min periods. For reasons given in the text, only two samplings were performed in the experiments with drugs. Drugs were administered to the organ bath between the first and second sampling period. Radioactivity in duplicate samples was measured from the inflow and outflow solutions. The sample (100 μl) was mixed with 3.0 ml of scintillation fluid (Ultima Gold XR, Packard). At least 10,000 decays were measured in a Packard scintillation counter (Packard 1900 TR Liquid scintillation analyzer). Net fluid transport was estimated from the rate of perfusion, and the radioactivity of the solutions entering and leaving the intestine was determined (26). The transmural PD of the intestinal segment was recorded by two electrodes. One electrode was connected by a T-tube to the inlet of the perfusion system and the other was in contact with the solution in the organ bath. The PD was continuously recorded on a polygraph.
22. Diarrhea in the mice was judged by a scoring system, with a score of 1 indicating unusually loose yellow stool and a score of 4 a completely loose stool A score of ≥2 (mucous with liquid stool, some loose but solid stool) was considered to indicate diarrhea. The scoring was performed by the same individual twice daily after administration of the rotavirus.
23. J. Cassuto, M. Jodal, O. Lundgren, Acta Physiol. Scand. 114, 573 (1982).
24. J. R Mathias and M. H. Clench, in Handbook of Physiology, section 6, The Gastrointestinal System, vol. 1, Motility and Circulation, S. Schultz, Ed. (American Physiological Society, Bethesda, MD, 1989), pp. 1153-1178.
25. B. Hille, Ionic Channels of Excitable Membranes (Sinauer, Sunderland, MA, ed. 2, 1992).
26. I. Brunsson, A. Sjöqvist, M. Jodal, O. Lundgren, Acta Physiol. Scand. 130, 633 (1987).
27. J. Cassuto, M. Jodal, R. Tuttle, O. Lundgren, Scand. J. Gastroenterol. 17, 695 (1982).
28. K. Weclewicz, L. Svensson, K. Kristensson, Brain Res. Bull. 46, 353 (1998).
29. A. Timar Peregrin, H. Ahlman, M. Jodal, O. Lundgren, Acta Physiol. Scand. 160, 379 (1997).
30. A. Sjöqvist, J. Fahrenkrug, M. Jodal, O. Lundgren, Acta Physiol. Scand. 133, 289 (1988); S. Eklund, A. Sjöqvist, J. Fahrenkrug, M. Jodal, O. Lundgren, Acta Physiol. Scand. 133, 551 (1988).
31. A. Sjöqvist, J. Fahrenkrug, M. Jodal, O. Lundgren, Acta Physiol. Scand. 133, 289 (1988); S. Eklund, A. Sjöqvist, J. Fahrenkrug, M. Jodal, O. Lundgren, Acta Physiol. Scand. 133, 551 (1988).
32. F. Ruggeri, K. Johansen, G. Basile, J-P. Kraehenbuhl, L. Svensson, J. Virol. 72, 2708 (1998).
33. L. Svensson, B. B. Finlay, D. Bass, C.-H. von Bonsdorff, H. B. Greenberg, J. Virol. 65, 4190 (1991)
34. O. Lundgren et al., unpublished observations.
35. W. G. Starkey et al., J. Pediatr Gastroenterol. Nutr. 11, 254 (1990).
36. H. Cooper, R. Levitan, J. S. Fordtran, F. J. Ingelfinger, Gastroenterology 50, 1 (1966).
37. Supported by grants 28255 and 10392 from the Swedish Medical Research Council, and by the Knut and Alice Wallenberg Foundation.